bicalutamide has been researched along with Osteoporosis in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, S; Furuya, K; Inoguchi, K; Miyakawa, M; Nagata, N; Nejishima, H; Yamamoto, N | 1 |
| Bian, J; Chen, R; Li, M; Li, Z; Tang, J; Tian, Y; Xie, Y; Xu, X; Zhang, Y; Zhang, Z | 1 |
| Cucalón, JM; Guiu, M | 1 |
| Carles Galceran, J; Celma Domenech, A; Lorente Garcia, D; Morote Robles, J; Placer Santos, J; Planas Morin, J; Regis, L; Salvador Lacambra, C; Trilla Herrera, E | 1 |
| Chesa, N; Déniz, F; Domínguez, C; Lara, PC; Lloret, M; Naranjo, A; Ojeda, S | 1 |
| Parr, NJ; Wadhwa, VK; Weston, R | 2 |
| Smith, MR | 3 |
| Fallon, MA; Goode, MJ; Smith, MR | 1 |
| Duncan, WE; Harding, P; Howard, RS; McLeod, DG; Preston, DM; Torréns, JI | 1 |
| Aslan, P; Bryant, C; Bucci, J; Diamond, TH; Kersley, JH; Lynch, WB | 1 |
| Anastasi, G; Franchina, F; Frisina, N; Galì, A; Gaudio, A; Magno, C; Maisano, D; Melloni, D; Morabito, N | 1 |
3 review(s) available for bicalutamide and Osteoporosis
| Article | Year |
|---|---|
Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998-2021).
Topics: Androgen Antagonists; Androgens; Humans; Osteoporosis; Receptors, Androgen; Structure-Activity Relationship | 2022 |
Osteoporosis during androgen deprivation therapy for prostate cancer.
Topics: Aged; Androgen Antagonists; Anilides; Bone and Bones; Bone Density; Bone Neoplasms; Estrogens; Fractures, Bone; Humans; Male; Middle Aged; Nitriles; Osteoporosis; Prostatic Neoplasms; Testosterone; Tosyl Compounds | 2002 |
Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma.
Topics: Absorptiometry, Photon; Alendronate; Androgen Antagonists; Anilides; Bone Density; Calcium; Gonadotropin-Releasing Hormone; Humans; Life Style; Male; Nitriles; Orchiectomy; Osteoporosis; Prostatic Neoplasms; Tosyl Compounds | 2003 |
2 trial(s) available for bicalutamide and Osteoporosis
| Article | Year |
|---|---|
Frequency of zoledronic acid to prevent further bone loss in osteoporotic patients undergoing androgen deprivation therapy for prostate cancer.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Bone Density Conservation Agents; Diphosphonates; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Male; Middle Aged; Nitriles; Osteoporosis; Prospective Studies; Prostatic Neoplasms; Tosyl Compounds; Zoledronic Acid | 2010 |
Preventing bone loss during androgen deprivation therapy for prostate cancer: early experience with neridronate.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Amino Acids; Androgen Antagonists; Anilides; Biomarkers; Bone Density; Calcium; Chromatography, High Pressure Liquid; Diphosphonates; Drug Therapy, Combination; Estradiol; Follow-Up Studies; Humans; Immunoenzyme Techniques; Male; Nitriles; Osteoporosis; Parathyroid Hormone; Phosphorus; Prostatic Neoplasms; Testosterone; Tosyl Compounds; Treatment Outcome; Vitamin D | 2005 |
9 other study(ies) available for bicalutamide and Osteoporosis
| Article | Year |
|---|---|
Tetrahydroquinolines as a novel series of nonsteroidal selective androgen receptor modulators: structural requirements for better physicochemical and biological properties.
Topics: Animals; Bone Density; Female; Osteoporosis; Ovariectomy; Quinolines; Rats; Receptors, Androgen | 2011 |
[The enigma of quaternary prevention in Primary Care. When and when not to do it (presentation of two cases)].
Topics: Aged, 80 and over; Androgen Antagonists; Anilides; Bone Density Conservation Agents; Cyproterone; Female; Humans; Inappropriate Prescribing; Indoles; Male; Nitriles; Osteoporosis; Primary Health Care; Prostatic Neoplasms; Tosyl Compounds | 2013 |
Bone mass behavior after 1 year of different treatment strategies in prostate cancer patients subjected to androgen deprivation therapy.
Topics: Aged; Aged, 80 and over; Alendronate; Androgen Antagonists; Anilides; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Diseases, Metabolic; Denosumab; Femur Neck; Humans; Leuprolide; Lumbar Vertebrae; Male; Nitriles; Osteoporosis; Prostatic Neoplasms; Radiography; Tosyl Compounds | 2014 |
Androgen deprivation in prostate cancer and the long-term risk of fracture.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Calcium; Combined Modality Therapy; Femur Neck; Follow-Up Studies; Fractures, Spontaneous; Gonadotropin-Releasing Hormone; Humans; Interviews as Topic; Lumbar Vertebrae; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Osteoporosis; Prospective Studies; Prostatic Neoplasms; Risk Assessment; Software; Tosyl Compounds; Vitamin D | 2017 |
Bicalutamide monotherapy preserves bone mineral density, muscle strength and has significant health-related quality of life benefits for osteoporotic men with prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Bone Density; Epidemiologic Methods; Humans; Male; Muscle Strength; Nitriles; Osteoporosis; Prostatic Neoplasms; Quality of Life; Tosyl Compounds; Treatment Outcome | 2011 |
Cross-sectional study of bone turnover during bicalutamide monotherapy for prostate cancer.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Cross-Sectional Studies; Estradiol; Fractures, Bone; Gonadotropin-Releasing Hormone; Humans; Male; Nitriles; Osteoblasts; Osteocalcin; Osteoclasts; Osteoporosis; Prostatic Neoplasms; Testosterone; Tosyl Compounds | 2003 |
Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
Topics: Absorptiometry, Photon; Adenocarcinoma; Aged; Amino Acids; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Biomarkers; Bone Density; Bone Remodeling; Calcium; Drug Therapy, Combination; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Neoplasms, Hormone-Dependent; Nitriles; Orchiectomy; Osteoporosis; Prospective Studies; Prostatic Neoplasms; Testosterone; Tosyl Compounds | 2002 |
Management of treatment-related osteoporosis in men with prostate cancer.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Diphosphonates; Estrogens; Gonadotropin-Releasing Hormone; Humans; Male; Nitriles; Orchiectomy; Osteoporosis; Prostatic Neoplasms; Selective Estrogen Receptor Modulators; Tosyl Compounds | 2003 |
Osteoporosis and spinal fractures in men with prostate cancer: risk factors and effects of androgen deprivation therapy.
Topics: Aged; Alcohol Drinking; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Comorbidity; Flutamide; Goserelin; Humans; Male; Multivariate Analysis; Nitriles; Osteoporosis; Prostatic Neoplasms; Retrospective Studies; Risk Factors; Spinal Fractures; Time Factors; Tosyl Compounds; Vitamin D | 2004 |